

Tirzepatide
Dual GIP/GLP-1 receptor agonist supplied lyophilized for metabolic research.
In stock · ships same day on orders before 2pm ET
| Quantity | Per unit | You save |
|---|---|---|
| 3 to 4 units | $93.00 | 7% |
| 5 to 9 units | $89.00 | 11% |
| 10+ units | $84.00 | 16% |
Verify lot TZ-2608-C in the COA library · This month's lot report
Ships same day on orders before 2pm ET. For laboratory research use only. Not for human or animal consumption.
Supplies researchers add to this order


What is Tirzepatide?
Tirzepatide is a 39-amino-acid synthetic peptide with dual agonist activity at the GIP and GLP-1 receptors. It is the reference compound for research into dual incretin signalling: how activating both receptors together affects insulin secretion, gastric emptying, appetite pathways and body composition in preclinical models. Pepstral supplies tirzepatide as a lyophilized powder, 10 mg net peptide per vial, tested by an independent US laboratory before listing.
→Read the full Tirzepatide research guide
What is Tirzepatide studied for?
- Dual incretin receptor signalling and cAMP assays
- Beta-cell function and insulin secretion models
- Appetite and gastric-emptying pathways
- Comparisons against GLP-1-only agonists
All applications above are in-vitro or preclinical research contexts. Tirzepatide is sold for laboratory research only and is not for human or animal use.
What does the certificate for lot TZ-2608-C show?
Every lot of Tirzepatide is tested by an independent US laboratory before it is listed. The report for lot TZ-2608-C is in the COA library and the lot number printed on the vial matches it. The current results:
| Test | Method | Lot TZ-2608-C result |
|---|---|---|
| Identity | LC-MS | Matches the calculated mass for the sequence |
| Purity | HPLC-UV, 220 nm | 99.2% |
| Net peptide content | Amino acid analysis | Stated per vial on the certificate |
| Endotoxin | LAL, chromogenic | < 0.5 EU/mg |
| Sterility | USP <71> | Pass |
How is Tirzepatide handled and stored?
Sealed vials are stored at -20°C away from light and keep for 24 months. To reconstitute, add bacteriostatic water slowly down the inside wall of the vial and swirl until clear; never shake. Once in solution, keep at 2 to 8°C and use within the 28-day window on the certificate. The reconstitution guide covers volumes and syringe units and the concentration table gives the numbers for this vial.
Frequently asked questions
How does tirzepatide differ from semaglutide in research use?
Semaglutide is GLP-1 selective. Tirzepatide adds GIP receptor activity, so it is chosen when the question involves both incretin pathways rather than one.
What purity does lot TZ-2608-C report?
99.2% by HPLC-UV at 220 nm, with identity confirmed by LC-MS and endotoxin below 0.5 EU per mg. The full certificate is in the COA library.
How long is tirzepatide stable after reconstitution?
Refrigerated at 2 to 8°C and protected from light, the certificate window is 28 days. Sealed lyophilized vials keep for 24 months at -20°C.
Is Tirzepatide for human use?
No. Every product on this site is sold for in-vitro laboratory research only and is not for human or animal consumption, diagnostic or therapeutic use.
Related reading
More in GLP-1 & Metabolic




